⌘K

16:08:00·164d

SECFilingvia Quantisnow

Amendment: SEC Form SCHEDULE 13G/A filed by Forte Biosciences Inc.

ByQuantisnow·Wall Street's wire, on your screen.

FBRX· Forte Biosciences Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

FBRX
Forte Biosciences Inc.
Health Care

Recent analyst ratings

Nov 25UpdateEvercore ISI$65.00
Aug 18UpdateGuggenheim$75.00
Jan 21UpdateTD Cowen-
Apr 8UpdateLadenburg Thalmann$2.75
Sep 20UpdateChardan Capital Markets$3.50
Sep 20UpdateChardan Capital$3.50

Related

SEC18d
SEC Form 424B5 filed by Forte Biosciences Inc.
SEC18d
SEC Form 8-K filed by Forte Biosciences Inc.
PR19d
Forte Biosciences Announces Pricing of $150 Million Public Offering
SEC19d
SEC Form 424B5 filed by Forte Biosciences Inc.
PR19d
Forte Biosciences Announces Proposed Public Offering
INSIDER24d
SEC Form 4 filed by Riley Antony A
INSIDER24d
SEC Form 4 filed by Wagner Paul A.
SEC26d
Forte Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition